Pediatrix Medical Group Inc (N:MD)

Business Focus: Healthcare Facilities & Services

Apr 22, 2024 06:45 am ET

Pediatrix Medical Group 2024 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 7, 2024

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2024. A detailed press release will be issued the morning of May 7, 2024 before the securities markets open.

Feb 20, 2024 06:00 am ET

Pediatrix Medical Group Reports Fourth Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported a loss from continuing operations of $1.50 per share for the three months ended December 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32.

Feb 13, 2024 06:45 am ET

Pediatrix® Medical Group to Host National Neonatology Meetings Feb. 19-24

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada. Specialty Review in Neonatology and

Feb 07, 2024 06:45 am ET

Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, February 20, 2024 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2023. A detailed press release will be issued the morning of February 20, 2024 before the securities markets open.

Nov 16, 2023 01:20 pm ET

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

November is Prematurity Awareness Month, Announcement Comes in Celebration of World Prematurity Day on Friday, Nov. 17

Nov 02, 2023 06:00 am ET

Pediatrix Medical Group Reports Third Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.26 per share for the three months ended September 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.32.

Oct 20, 2023 06:45 am ET

Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2023. A detailed press release will be issued the morning of November 2, 2023 before the securities markets open.

Aug 03, 2023 06:00 am ET

Pediatrix Medical Group Reports Second Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.34 per share for the three months ended June 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.39.

Jul 18, 2023 06:45 am ET

Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2023. A detailed press release will be issued the morning of August 3, 2023 before the securities markets open.

May 04, 2023 04:05 pm ET

Pediatrix Board Appoints Sylvia Young as Independent Director

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023.

May 03, 2023 06:45 am ET

Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, May 9, 2023 at 5:00 pm PT to investors attending the 2023 Bank of America Health Care Conference in Las Vegas, Nevada. The presentation will be broadcast through live audio webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/

May 02, 2023 06:00 am ET

Pediatrix Medical Group Reports First Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.17 per share for the three months ended March 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.23.

Apr 26, 2023 06:45 am ET

Pediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2023. A detailed press release will be issued the morning of May 2, 2023 before the securities markets open.

Mar 08, 2023 05:36 pm ET

James D. Swift, M.D., Elected to Pediatrix Board of Directors

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D.

Feb 21, 2023 06:45 am ET

Pediatrix® Medical Group to Host National Neonatology Meeting Feb. 22-24

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medicine Feb. 22-24 in Las Vegas, Nevada. More than 385 physicians, allied health professionals, advanced practitioners/registered nurses, residents/fellows and exhibitors are expected to attend NEO: The Conference for Neonatology, where experts will address many of the most critical and controversial issues that influence the clinical practice of newborn medicine.

Feb 17, 2023 06:00 am ET

Pediatrix Medical Group Reports Fourth Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.29 per share for the three months ended December 31, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47.

Feb 06, 2023 06:45 am ET

Pediatrix Medical Group 2022 Fourth Quarter Conference Call/Webcast Scheduled for Friday, February 17, 2023

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, February 17, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2022. A detailed press release will be issued the morning of February 17, 2023 before the securities markets open.

Dec 15, 2022 04:41 pm ET

Pediatrix Announces Leadership Transitions

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today announced that the Company’s board of directors has appointed James D. Swift, M.D., as chief executive officer, to succeed Mark S. Ordan, who has been named executive chair of the Company’s board of directors and has served as chief executive officer since July 2020. Guy P. Sansone, who previously served as chair of the Company’s board of directors since July 2020, has been named lead independent director. Each of these transitions will go into effect

Dec 01, 2022 06:50 am ET

Pediatrix® Medical Group Releases Inaugural Sustainability Report

Pediatrix® Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today released its inaugural sustainability report which outlines Pediatrix’s approach and business practices related to its Environmental, Social and Governance (ESG) efforts. The report is a milestone in the company’s commitment to transparently providing ESG information to its key stakeholders.

Nov 07, 2022 06:45 am ET

Pediatrix Medical Group to Present at Credit Suisse 31st Annual Healthcare Conference

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, November 8, 2022 at 3:15 p.m. PT to investors attending the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, California. The presentation will be broadcast through live audio webcasts.

Nov 03, 2022 06:00 am ET

Pediatrix Medical Group Reports Third Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.35 per share for the three months ended September 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.40.

Oct 21, 2022 06:45 am ET

Pediatrix Medical Group 2022 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 3, 2022

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 3, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2022. A detailed press release will be issued the morning of November 3, 2022 before the securities markets open.

Aug 22, 2022 03:00 pm ET

Pediatrix Medical Group Comments on No Surprises Act Final Rule

Pediatrix Medical Group, Inc. (NYSE: MD) today provided commentary on the final rule issued on August 19, 2022 by the Departments of the Treasury, Labor, and Health and Human Services related to the No Surprises Act.

Aug 04, 2022 06:00 am ET

Pediatrix Medical Group Reports Second Quarter Results

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.36 per share for the three months ended June 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47.

Jul 13, 2022 06:45 am ET

Pediatrix Medical Group 2022 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 4, 2022

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 4, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2022. A detailed press release will be issued the morning of August 4, 2022 before the securities markets open.

Jun 21, 2022 06:45 am ET

Mednax To Change Name to Pediatrix Medical Group, Inc. Effective July 1, 2022

Mednax, Inc. (NYSE: MD) today announced that it will change its corporate name to Pediatrix Medical Group, Inc., effective after the close of the market on July 1, 2022. The Company’s common stock will continue to trade on the New York Stock Exchange under the current ticker symbol “MD.”

May 18, 2022 06:45 am ET

Mednax Announces Leadership Appointments

Mednax, Inc. (NYSE: MD) today announced two appointments to further strengthen its operating and clinical leadership. The Company named James D. Swift, M.D. as Chief Operating Officer and Curtis B. Pickert, M.D. as Chief Physician Executive. Both Drs. Swift and Pickert have been with the Company for over a decade and have held expanding leadership roles over that time.

Apr 28, 2022 06:00 am ET

Mednax Reports First Quarter Results

Mednax, Inc. (NYSE: MD), whose affiliated practices operate as Pediatrix® Medical Group, the nation’s leading provider of highly specialized health care for women, children and babies, today reported a loss from continuing operations of $0.25 per share for the three months ended March 31, 2022. Results from continuing operations include a pretax loss on early extinguishment of debt of $57 million. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.33.

Apr 19, 2022 06:45 am ET

Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, April 28, 2022 at 9:00 a.m. ET, to discuss results from operations for the quarter ended March 31, 2022. A detailed press release will be issued the morning of April 28, 2022 before the securities markets open.

Mar 02, 2022 07:00 am ET

Mednax-Affiliated Practices to Adopt Pediatrix® Brand

Mednax, Inc. (NYSE: MD) today announced that its affiliated practices will adopt the Pediatrix® Medical Group brand nationwide, reflecting the group’s role as the nation’s leading provider of highly specialized health care for women, babies and children.

Feb 24, 2022 07:00 am ET

Pediatrix® to Host Premier Neonatology Meetings March 1-6

Mednax, Inc. (NYSE: MD) and its Pediatrix-affiliated practices, the nation’s leading providers of highly specialized health care for women, children and babies, will host two premier meetings in neonatal medicine at the Manchester Grand Hyatt in San Diego March 1-6. Specialty Review in Neonatology and NEO: The Conference for Neonatology will take place concurrently, each addressing many of the most critical and controversial issues that influence the clinical practice of newborn medicine.

Feb 23, 2022 07:00 am ET

Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

Mednax, Inc. (NYSE: MD) today announced that it will present on Monday, February 28, 2022 at 10:00 a.m. ET to investors attending J.P. Morgan’s 2022 Global High Yield and Leveraged Finance Conference in Miami. The presentation will be broadcast through live audio webcasts.

Feb 17, 2022 06:45 am ET

Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference

Mednax, Inc. (NYSE: MD) today announced that it will present on Friday, February 18, 2022 at 8:40 a.m. ET to investors attending SVB Leerink’s 11th Annual Global Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts.

Feb 17, 2022 06:00 am ET

Mednax Reports Fourth Quarter Results

Mednax, Inc. (NYSE: MD), and its affiliated practices operating as Pediatrix® Medical Group, the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.47 per share for the three months ended December 31, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.52.

Feb 14, 2022 06:45 am ET

Mednax Announces Closing of $1.1 Billion in Financing Transactions

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today that on February 11, 2022 it closed the previously announced issuance of $400.0 million aggregate principal amount of unsecured 5.375% Senior Notes due 2030 (the “Notes”) in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). Mednax concurrently closed on a new $450 million unsecured Revolving Credit Facility and a new $250 million Term A Loan, replacing its previous $600 million unsecured Revolving Credit Facility.

Feb 07, 2022 06:45 am ET

Mednax 2021 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 17, 2022

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, February 17, 2022 at 9:00 a.m. ET, to discuss results from operations for the quarter and the year ended December 31, 2021. A detailed press release will be issued the morning of February 17, 2022 before the securities markets open.

Feb 04, 2022 07:00 am ET

Pediatrix® Expands Presence in Florida Through Affiliation with 13-Clinic Pediatric Urgent Care Practice

Mednax, Inc. (NYSE: MD) and its affiliated practices operating as Pediatrix® Medical Group (Pediatrix), the nation’s leading provider of highly specialized health care for women, children and babies, today announced the acquisition of Night Lite Pediatrics, LLC (Night Lite Orlando or NLO), a private 13-clinic pediatric urgent care practice based in Orlando, Florida.

Feb 02, 2022 06:17 pm ET

Mednax Prices Private Offering of $400 Million Senior Notes Due 2030

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today the pricing of $400.0 million aggregate principal amount of 5.375% Senior Notes due 2030 (the “Notes”) in a private offering (the “Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Offering is expected to close on February 11, 2022, subject to customary closing conditions.

Feb 01, 2022 08:47 am ET

Mednax Launches Private Offering of $400 Million Senior Notes Due 2030

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today that it is proposing to issue $400.0 million in aggregate principal amount of Senior Notes due 2030 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The proposed offering of Notes is subject to market and other conditions.

Nov 19, 2021 07:00 am ET

Mednax to Present at Bank of America 2021 Leveraged Finance Conference

Mednax, Inc. (NYSE: MD) today announced that it will present on Tuesday, November 30, 2021 at 2:15 p.m. EST to investors attending Bank of America’s 2021 Leveraged Finance Conference, taking place virtually. The presentation will be broadcast through live audio webcasts.

Nov 09, 2021 04:15 pm ET

Mednax to Present at Credit Suisse 30th Annual Healthcare Conference

Mednax, Inc. (NYSE: MD) today announced that it will present on Wednesday, November 10, 2021 at 1:50 p.m. EST to investors attending Credit Suisse’s 30th Annual Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts.

Oct 28, 2021 06:00 am ET

Mednax Reports Third Quarter Results

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.37 per share for the three months ended September 30, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.46.

Oct 18, 2021 06:45 am ET

Mednax 2021 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 28, 2021

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, October 28, 2021 at 9:00 a.m. ET, to discuss results from operations for the quarter and nine months ended September 30, 2021. A detailed press release will be issued the morning of October 28, 2021 before the securities markets open.

Oct 13, 2021 06:45 am ET

Mednax Clinical Leadership Urges Full Vaccination and All Measures to Protect Expecting Mothers and Children During COVID-19 Pandemic

Mednax®, Inc. (NYSE: MD), its clinical leadership, and that of its affiliated Pediatrix® and Obstetrix® Medical Groups today provided full support of the Centers for Disease Control and Prevention (CDC) and other medical associations’ recommendations that all eligible Americans become vaccinated against COVID-19. This support is consistent with Mednax’s long-standing commitment to the well-being of its affiliated medical practices’ patients nationwide, who consist of women undergoing high-risk pregnancies, critically ill and premature newborns and children in need of specialized and, in many c

Oct 07, 2021 09:00 am ET

Brave Care, The Leader in Technology-Powered Pediatric Clinics, Raises $25M in Series B Investment led by Mednax, Inc.

PORTLAND, Ore., Oct. 7, 2021 /PRNewswire/ -- Brave Care, the first pediatric healthcare and technology platform dedicated to improving primary and urgent care for children, today announced it has raised $25M. The round was led by Mednax, Inc. NYSE: MD, whose Chief Development Officer, Dr. Jim Swift, also has been added to Brave Care's Board of Directors.

Oct 07, 2021 06:45 am ET

Mednax and Brave Care to Accelerate Transformation of Pediatric Primary and Urgent Care

Mednax, Inc. (NYSE: MD) and privately owned Brave Care today announced an agreement through which the two companies will develop new, innovative pediatric primary and urgent care clinics throughout the United States, with the goal of significantly enhancing the provision of pediatric care.

Oct 05, 2021 05:09 pm ET

The Pediatrix® and Obstetrix® Medical Group Reports Surge in Critically Ill Pregnant Patients with the COVID-19 Delta Variant

The Pediatrix® and Obstetrix® Medical Group, affiliates of Mednax®, Inc. (NYSE: MD) and leading providers of maternal-fetal medicine (MFM) and obstetric (OB) services, reports that its affiliated clinicians are treating more pregnant women critically ill with COVID-19 than at any point in the pandemic. Pregnant patients remain largely unvaccinated, despite a strong endorsement from the Centers for Disease Control and Prevention (CDC), The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM).

Sep 08, 2021 06:45 am ET

Mednax to Present at Morgan Stanley 19th Annual Global Healthcare Conference

Mednax, Inc. (NYSE: MD) today announced that it will present on Wednesday, September 15, 2021 at 12:30 p.m. ET to investors attending Morgan Stanley’s 19th Annual Global Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts.

Aug 06, 2021 06:00 am ET

Mednax Reports Second Quarter Results

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.36 per share for the three months ended June 30, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.41.

Jul 15, 2021 06:45 am ET

Mednax 2021 Second Quarter Conference Call/Webcast Scheduled for Friday, August 6, 2021

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, August 6, 2021 at 9:00 a.m. ET, to discuss results from operations for the quarter and six months ended June 30, 2021. A detailed press release will be issued the morning of August 6, 2021 before the securities markets open.

Jul 14, 2021 04:15 pm ET

Mednax Announces CVS Aetna Voluntarily Dismisses 2018 Litigation

Mednax, Inc. (NYSE: MD) announced today that CVS Aetna has voluntarily dismissed its litigation against the Company.

May 07, 2021 06:00 am ET

Mednax Reports First Quarter Results

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.06 per share for the three months ended March 31, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.24.

Apr 22, 2021 06:45 am ET

Mednax 2021 First Quarter Conference Call/Webcast Scheduled for Friday, May 7, 2021

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, May 7, 2021 at 9:00 a.m. ET, to discuss results from operations for the quarter ended March 31, 2021. A detailed press release will be issued the morning of May 7, 2021 before the securities markets open.

Mar 16, 2021 09:24 am ET

Mednax Expands Presence in Texas through Affiliation with Eight-Clinic Pediatric Urgent Care Practice

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal and pediatric services, today announced its affiliation with NightLight Pediatric Urgent Care (NightLight), a private eight-clinic practice based in Houston. The affiliation with NightLight is the first step in a new strategy to reimagine pediatric ‘total’ care for patients in select markets throughout the country.

Feb 22, 2021 06:45 am ET

Mednax to Present at Upcoming Investor Conferences

Mednax, Inc. (NYSE: MD) today announced that it is scheduled to make presentations at two upcoming investor conferences.

Feb 18, 2021 06:00 am ET

Mednax Reports Fourth Quarter Results

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.05 per share for the three months ended December 31, 2020. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.25.

Feb 05, 2021 06:45 am ET

Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 18, 2021

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, February 18, 2021 at 9:00 a.m. ET, to discuss results from operations for the quarter and the year ended December 31, 2020. A detailed press release will be issued the morning of February 18, 2021 before the securities markets open.

Jan 26, 2021 06:45 am ET

Mednax’s NEO: The Conference for Neonatology Goes Virtual Feb. 15-19

Mednax, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal and pediatric services, will host NEO: The Conference for Neonatology Feb. 15-19. NEO is recognized as one of the top neonatology meetings in the U.S. Now in its 42nd year, the 2021 event will take place via an interactive virtual platform, offering a unique opportunity to engage and network with peers while continuing its longstanding tradition of providing the latest information on key areas of neonatal management to improve newborn outcomes.

Jan 19, 2021 11:10 am ET

Federman & Sherwood Files First Data Breach Case Against MedNax, Inc. and Pediatrix Medical Group, a MedNax Company

The law firm of Federman & Sherwood has filed the first data breach case against MedNax, Inc. (“MedNax”) (NYSE: MD) and Pediatrix Medical Group, a MedNax Company (“Pediatrix”) with respect to possible violations of state and federal consumer laws for a data breach incident that MedNax announced on or around December 16, 2020.

Dec 16, 2020 06:45 am ET

MEDNAX Completes Sale of MEDNAX Radiology Solutions to Radiology Partners

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, and pediatric services, today announced that it has completed the previously announced sale of MEDNAX Radiology Solutions to Radiology Partners for total consideration of $885 million. The Company received net proceeds, after related transaction expenses and customary adjustments, of approximately $865 million.

Nov 06, 2020 06:00 am ET

MEDNAX Reports Third Quarter Results

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, and pediatric services, today reported a net loss of $41.0 million, or $0.49 per share for the three months ended September 30, 2020, primarily reflecting a non-cash loss on the classification of the MEDNAX Radiology Solutions medical group to assets held for sale. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.37.

Nov 05, 2020 05:40 pm ET

MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600

NEW YORK, Nov. 5, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and SmallCap 600 effective prior to the opening of trading on Friday, November 13:

Oct 20, 2020 06:45 am ET

MEDNAX 2020 Third Quarter Conference Call/Webcast Scheduled for Friday, November 6, 2020

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Friday, November 6, 2020 at 9:00 a.m. ET, to discuss results from operations for the three and nine months ended September 30, 2020. A detailed press release will be issued the morning of November 6, 2020 before the securities markets open.

Sep 10, 2020 06:55 am ET

Radiology Partners Signs Definitive Agreement to Acquire MEDNAX Radiology Solutions

Radiology Partners (RP), the leading radiology practice in the U.S., today announced a definitive agreement to acquire MEDNAX Radiology Solutions, a division of MEDNAX, Inc. (NYSE: MD), in a transaction with an enterprise value of approximately $885 million. The combination of RP and MEDNAX Radiology Solutions brings together two of the top rad

Sep 10, 2020 06:45 am ET

MEDNAX Announces Agreement to Sell MEDNAX Radiology Solutions to Radiology Partners

MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, today announced a definitive agreement pursuant to which Radiology Partners will acquire MEDNAX Radiology Solutions for $885 million to create a leading provider of comprehensive radiology and teleradiology services in the United States. MEDNAX previously announced its intent to sell MEDNAX Radiology Solutions, and this agreement follows substantive discussions and due diligence with several parties before identifying Radiology Partners as the strongest partner for MEDNAX’s radiol

Aug 25, 2020 06:50 am ET

MEDNAX Announces Financial Leadership Transition

MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, today announced that C. Marc Richards has been appointed as Executive Vice President. The Company anticipates that Mr. Richards will assume the additional role of Chief Financial Officer in October 2020, succeeding Stephen D. Farber, who has announced his plan to depart the Company to pursue other leadership opportunities.

Jul 30, 2020 06:00 am ET

MEDNAX Reports Second Quarter Results

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, pediatric, and radiology services, today reported a net loss of $8.03 per share for the three months ended June 30, 2020, primarily reflecting a non-cash loss on sale related to the Company’s previously announced divestiture of American Anesthesiology. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.32.

Jul 17, 2020 10:30 am ET

Jefferson Radiology Announces Implementation of iCAD ProFound AI™ Platform Across Its Enterprise

Jefferson Radiology is implementing state-of-the-art artificial intelligence software for digital breast tomosynthesis (DBT) to improve cancer detection rates and enhance overall quality of patient care. iCAD ProFound AITM is an advanced deep-learning, cancer detection software solution that has been shown to detect more cancers, with fewer unnecessary callbacks, and in less than half the time1. Jefferson Radiology is not only the first, but currently the only practice in the state of Connecticut to offer ProFound AITM.

Jul 16, 2020 07:00 am ET

MEDNAX 2020 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2020

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, July 30, 2020 at 10:00 a.m. ET, to discuss results from operations for the quarter and six months ended June 30, 2020. A detailed press release will be issued the morning of July 30, 2020 before the securities markets open.

Jul 13, 2020 06:55 am ET

MEDNAX Announces Leadership and Board Transitions

MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, today announced that the Company’s Board of Directors has appointed Mark S. Ordan as Chief Executive Officer, succeeding Roger J. Medel, M.D., the Company’s founder. Dr. Medel will remain a member of the Board until the 2021 Annual Meeting of Shareholders.

Jun 16, 2020 07:00 am ET

MEDNAX to Exhibit at the ATA2020 Virtual Conference June 22-26

MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, will exhibit at the American Telemedicine Association (ATA) Virtual Conference from June 22-26, 2020.

Jun 05, 2020 06:50 am ET

MEDNAX Announces Significant Progress in Strategic Transformation

MEDNAX, Inc. (NYSE: MD), a leading health solutions partner specializing in prenatal, neonatal, pediatric, and radiology services, today announced a number of further steps it is taking as part of its aggressive transformational activity to position the Company for long-term, sustainable growth.

Jun 01, 2020 04:15 pm ET

MEDNAX Business Update Conference Call/Webcast Scheduled for Friday, June 5, 2020

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Friday, June 5, 2020 at 9:00 a.m. ET, to provide a business update. A detailed press release will be issued the morning of June 5, 2020 before the securities markets open.

May 12, 2020 04:14 pm ET

Jefferson Radiology, an Affiliate of MEDNAX, Develops New Collaborative Partnership with the Center for Diagnostic Imaging

Jefferson Radiology, an affiliate of MEDNAX (NYSE:MD) and Center for Diagnostic Imaging (CDI) today announced the launch of a new collaborative agreement for CDI’s Springfield location, combining physician excellence with industry leading technological capabilities to further cement their reputations as providers of choice in the Springfield market.

May 07, 2020 06:00 am ET

MEDNAX Reports First Quarter Results

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, pediatric, and radiology services, today reported a loss from continuing operations of $0.20 per share for the three months ended March 31, 2020. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.32.

May 06, 2020 08:55 am ET

North American Partners in Anesthesia (NAPA) Acquires American Anesthesiology From MEDNAX, Inc., to Create One of the Most Comprehensive Anesthesia, Pain Management, and Perioperative Care Companies i

North American Partners in Anesthesia (NAPA) and MEDNAX, Inc. (NYSE: MD) today jointly announced the completion of NAPA’s acquisition of American Anesthesiology, a MEDNAX medical group, creating the destination of choice for anesthesia, pain management, and perioperative care in the United States.

Apr 21, 2020 07:00 am ET

MEDNAX 2020 First Quarter Conference Call/Webcast Scheduled for Thursday, May 7, 2020

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, May 7, 2020 at 10:00 a.m. ET, to discuss results from operations for the quarter ended March 31, 2020. A detailed press release will be issued the morning of May 7, 2020 before the securities markets open.

Apr 10, 2020 07:00 am ET

MEDNAX Responds to Coronavirus Pandemic

MEDNAX, Inc. (NYSE: MD), a leading health solutions partner specializing in prenatal, neonatal, pediatric, anesthesiology and radiology services, today announced the proactive steps it has been taking in response to the rapidly evolving Coronavirus (COVID-19) pandemic. Clinicians are collaborating across the continuum of care to develop innovative solutions and best practices that are leading early detection efforts and enabling safe, uninterrupted patient care.

Mar 25, 2020 06:45 am ET

MEDNAX Provides COVID-19-Related Business Update

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine and other pediatric services, today provided an update on its operations in response to the continued spread of Coronavirus (COVID-19).

Mar 12, 2020 06:45 am ET

Obstetrix Medical Group Launches HRO Program for Labor & Delivery

MEDNAX, Inc. (NYSE:MD) affiliate Obstetrix Medical G

Feb 20, 2020 06:00 am ET

MEDNAX Reports Fourth Quarter Results

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, and other pediatric services, today reported earnings from continuing operations of $0.40 per share for the three months ended December 31, 2019. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.91.

Feb 14, 2020 06:45 am ET

MEDNAX to Host Two Premier Neonatology Meetings Feb. 17-22

MEDNAX, Inc. (NYSE: MD), the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty care, will host two premier meetings in neonatal medicine this month at the Manchester Grand Hyatt in San Diego. Specialty Review in Neonatology and NEO: The Conference for Neonatology will take place concurrently, each addressing many of the most critical and controversial issues that influence the clinical practice of newborn medicine. The meetings will host more than 700 combined attendees.

Feb 05, 2020 05:29 pm ET

MEDNAX Congratulates Pediatrix Medical Group of Kansas and Saint Luke’s Hospital of Kansas City for Care of Micro-Preemie Baby Honored at State of the Union

Last night’s State of the Union Address included recognition of an incredible success story where the life of a 21-week premature baby was saved at Saint Luke’s Hospital of Kansas City. MEDNAX, Inc. (NYSE: MD) wishes to recognize Saint Luke’s and Pediatrix Medical Group of Kansas, a MEDNAX-affiliated neonatology practice, which clinically managed the care of this baby.

Jan 30, 2020 06:45 am ET

MEDNAX 2019 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2020

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, February 20, 2020 at 9:00 a.m. ET, to discuss results from operations for the quarter and the year ended December 31, 2019. A detailed press release will be issued the morning of February 20, 2020 before the securities markets open.

Jan 06, 2020 06:45 am ET

MEDNAX Expands Presence in Florida through Affiliation with Leading Radiology Practice

MEDNAX, Inc. (NYSE: MD) today announced its affiliation with Boca Radiology Group, P.A., a private radiology physician group based in Boca Raton, Fla. The practice will integrate with Radiology Associates of South Florida, LLC (RASF), a MEDNAX-affiliated physician practice located in Miami and serving all of South Florida.

Nov 22, 2019 06:45 am ET

MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Critical Care and Hospitalist Practice

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Arcenio Chacón, M.D., P.A. and Associated Pediatricians of Homestead, LLC, a private pediatric critical care and hospitalist practice based in Miami.

Nov 21, 2019 06:45 am ET

MEDNAX Radiology Solutions and vRad to Exhibit at the RSNA 2019 Annual Meeting Dec. 1-6

MEDNAX Radiology Solutions, one of the nation’s leading radiology practices, and Virtual Radiologic (vRad),

Nov 12, 2019 06:45 am ET

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

Nov 01, 2019 06:00 am ET

MEDNAX Reports Third Quarter Results

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, and other pediatric services, today reported results from continuing operations for the three months ended September 30, 2019.

Oct 31, 2019 06:45 am ET

MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Plastic Surgery Practice

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Eric Stelnicki, M.D., P.A., a private pediatric plastic surgery practice based in Fort Lauderdale, Fla.

Oct 18, 2019 10:30 am ET

American Anesthesiology, a MEDNAX Company, to Exhibit at the ANESTHESIOLOGY® 2019 Annual Meeting Oct. 19-21

American Anesthesiology, a MEDNAX company and leading anesthesiology physician services provider, will exhibit at the ANESTHESIOLOGY® 2019 annual meeting presented by the American Society of Anesthesiologists (ASA) from Oct. 19-21 at the Orange County Convention Center in Orlando, Fla.

Oct 15, 2019 06:45 am ET

MEDNAX 2019 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2019

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Friday, November 1, 2019 at 9:00 a.m. ET, to discuss results from operations for the quarter and the nine months ended September 30, 2019. A detailed press release will be issued the morning of November 1, 2019 before the securities markets open.

Oct 10, 2019 06:50 am ET

MEDNAX Reaches Agreement to Sell MedData Business to Frazier Healthcare Partners

MEDNAX, Inc. (NYSE:MD) (“MEDNAX” or “the Company”) and Frazier Healthcare Partners (“Frazier”) today announced that they have entered into a definitive agreement under which MEDNAX will sell its MedData business to Frazier.

Sep 12, 2019 06:45 am ET

MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Otolaryngology Practice

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with CENTA, P.L., a private pediatric otolaryngology practice based in Orlando, Fla.

Aug 30, 2019 06:45 am ET

Indiana Neonatology Practice Joins MEDNAX

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Northern Indiana Neonatal Associates, P.C., a private neonatology practice based in Fort Wayne, Ind.

Aug 16, 2019 06:45 am ET

MEDNAX Hosts 10th Annual Innovations in Neonatal Care Conference

MEDNAX, Inc. (NYSE: MD), a leading national health solutions provider, hosted its 10th annual Innovations in Neonatal Care conference in Austin, Texas, from August 11-13. The event is accredited by the MEDNAX Center for Research, Education, Quality and Safety (CREQS) and provides continuing medical and nursing education credit for participating clinicians.

Aug 14, 2019 06:45 am ET

MEDNAX Expands Presence in Nevada through Affiliation with Leading Pediatric Neurology Practice

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Halthore Maller Pediatric Neurology Associates, LTD, a private pediatric neurology practice based in Las Vegas.

Aug 09, 2019 01:38 pm ET

MEDNAX’s American Anesthesiology to Exhibit at the American Association of Nurse Anesthetists 2019 Annual Congress August 11-13

MEDNAX, Inc. (NYSE: MD), a leading national health solutions provider, will exhibit at the American Association of Nurse Anesthetists (AANA) 2019 Annual Congress from August 11-13 at the Hyatt Regency Chicago. Clinical leadership and recruiters from American Anesthesiology, a MEDNAX company, will be on-site at booth #912 and at the Career Fair at kiosk #8, where leadership will present on investing in the future of nurse anesthesia. Additionally, the Company announces its appointment of Kevin Smith, Certified Registered Nurse Anesthetist (CRNA), as Interim Vice President of Advanced Practice A

Aug 01, 2019 06:00 am ET

MEDNAX Reports Second Quarter GAAP EPS from Continuing Operations of $0.42; Adjusted EPS from Continuing Operations of $0.89

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings from continuing operations of $0.42 per diluted share for the three months ended June 30, 2019. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.89.

Jul 24, 2019 06:45 am ET

MEDNAX to Exhibit at the 2019 American Hospital Association Leadership Summit July 25-26

MEDNAX, Inc. (NYSE: MD), a leading national health solutions provider, will exhibit at the 2019 American Hospital Association (AHA) Leadership Summit from July 25-26 at the Manchester Grand Hyatt in San Diego, Calif. Company leadership will be on-site at booth #307.

Jul 19, 2019 06:45 am ET

MEDNAX Radiology Solutions and vRad to Exhibit at AHRA 2019 Annual Meeting July 22-24

MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, and vRad (Virtual Radiologic), a MEDNAX company, will exhibit at AHRA: The Association for Medical Imaging Management’s 2019 Annual Meeting from July 22-24 in Denver, Co. MEDNAX leadership will be on-site at booth #314.

Jul 16, 2019 06:45 am ET

MEDNAX 2019 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 1, 2019

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, August 1, 2019 at 10:00 a.m. ET, to discuss results from operations for the quarter and the six months ended June 30, 2019. A detailed press release will be issued the morning of August 1, 2019 before the securities markets open.

Jun 14, 2019 06:45 am ET

Texas Maternal-Fetal Medicine Practice Joins MEDNAX

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Alfredo Gei MD, P.A., a private maternal-fetal medicine practice based in Houston.

May 28, 2019 06:45 am ET

MEDNAX to Present at the Jefferies 2019 Global Healthcare Conference

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make a presentation on Tuesday, June 4, 2019 at 2:30 p.m. ET to investors attending the Jefferies 2019 Global Healthcare Conference in New York.

May 07, 2019 06:45 am ET

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

May 03, 2019 06:45 am ET

California Maternal-Fetal Medicine Practice Joins MEDNAX

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Central Coast Perinatal Medical Group, Inc., a private maternal-fetal medicine practice based in Santa Barbara, Calif.

May 02, 2019 06:00 am ET

MEDNAX Reports First Quarter GAAP EPS from Continuing Operations of $0.48; Adjusted EPS from Continuing Operations of $0.65

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings from continuing operations of $0.48 per diluted share for the three months ended March 31, 2019. On a non-GAAP basis, MEDNAX reported Adjusted EPS from continuing operations of $0.65.

Apr 17, 2019 06:45 am ET

MEDNAX 2019 First Quarter Conference Call/Webcast Scheduled for Thursday, May 2, 2019

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, May 2, 2019 at 10:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2019. A detailed press release will be issued the morning of May 2, 2019 before the securities markets open.

Mar 29, 2019 06:45 am ET

Georgia Neonatology Practice Joins MEDNAX

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Georgia Neonatology, LLC, a private neonatology practice based in Athens, Ga.

Mar 28, 2019 06:45 am ET

MEDNAX Announces Board of Directors Nominees

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the nomination of Carlos A. Migoya and Michael A. Rucker to stand for election to the Company’s Board of Directors at its Annual Meeting of Shareholders on May 16, 2019.

Feb 26, 2019 08:30 am ET

Report: Exploring Fundamental Drivers Behind IHS Markit, Mednax, HFF, Scientific Games, El Pollo Loco, and Plexus — New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of IHS Markit Ltd. (NASDAQ:INFO), Mednax, Inc (NYSE:MD), HFF, Inc. (NYSE:HF),...

Feb 25, 2019 02:46 pm ET

MedData's New RCM Technology Solution Accelerates Reimbursement for Providers

MedData, a MEDNAX (NYSE: MD) company and a leading provider of technology-enabled management services for hospitals and healthcare providers, today announced the launch of MedData FastTrack, a tech-infused solution for faster reimbursement.

Feb 21, 2019 05:13 pm ET

MEDNAX Announces Closing of $500 Million of 6.250% Senior Notes Due 2027

MEDNAX, Inc. (NYSE:MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $491.7 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the

Feb 21, 2019 06:45 am ET

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

Feb 19, 2019 05:00 pm ET

MEDNAX Announces Pricing of $500 Million of 6.250% Senior Notes Due 2027

MEDNAX, Inc. (NYSE: MD), announced today the pricing of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act. The Notes will be issued as additional notes under an indenture, dated as o

Feb 19, 2019 07:30 am ET

MEDNAX Launches Private Offering of $200 Million of 6.250% Senior Notes Due 2027

MEDNAX, Inc. (NYSE: MD), announced today that it is proposing to issue $200 million aggregate amount of 6.250% senior notes due 2027 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be issued as additional notes under an indenture, dated as of December 8, 2015, as supplemented by Supplemental Indenture No. 5 thereto, dated as of November 13, 2018 (collectively, the “Indenture”), pursuant to which the Company

Feb 07, 2019 06:00 am ET

MEDNAX Reports Fourth Quarter GAAP EPS of $0.68; Adjusted EPS of $0.92

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.68 per diluted share for the three months ended December 31, 2018. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $0.92.

Jan 29, 2019 08:25 am ET

Market Trends Toward New Normal in Colgate-Palmolive, Mednax, The Cheesecake Factory, Avid Technology, XPO Logistics, and Pier 1 Imports — Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Colgate-Palmolive Company (NYSE:CL), Mednax, Inc (NYSE:MD), The Cheesecake...

Jan 17, 2019 06:45 am ET

MEDNAX 2018 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 7, 2019

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, February 7, 2019 at 10:00 a.m. ET, to discuss results from operations for the quarter and the twelve months ended December 31, 2018. A detailed press release will be issued the morning of February 7, 2019 before the securities markets open.

Dec 14, 2018 06:45 am ET

MEDNAX Announces Completion of $250 Million Accelerated Share Repurchase Program

MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million accelerated share repurchase (ASR) program previously announced on September 4, 2018. Under the terms of the ASR, the Company repurchased approximately 5.9 million shares of its common stock at an average price of $42.47 per share.

Nov 28, 2018 06:45 am ET

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

Nov 27, 2018 06:45 am ET

MEDNAX Radiology Solutions Launches Artificial Intelligence Incubator to Stimulate Innovation While Driving Adoption in Radiology

MEDNAX, Inc. (NYSE: MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The MDR-AI Incubator brings together radiologists, a rich clinical dataset, and a select group of technology partners that

Nov 26, 2018 01:30 pm ET

CORRECTING and REPLACING MEDNAX Continues Its Expansion in Radiology with the Acquisition of Another Leading South Florida Radiology Practice

Third paragraph, second sentence of release should read: In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Bethesda Health Urgent Care. (instead of In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Wellington Regional Medical Center’s Outpatient Diagnostic Center.).

Nov 21, 2018 06:45 am ET

MEDNAX Radiology Solutions and vRad to Exhibit at RSNA 2018 Annual Meeting Nov. 25-29

MEDNAX, Inc. (NYSE:MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, which includes vRad (Virtual Ra

Nov 13, 2018 04:56 pm ET

MEDNAX Announces Closing of $500 Million of 6.250% Senior Notes Due 2027

MEDNAX, Inc. (NYSE:MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $492.5 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the

Nov 12, 2018 07:50 am ET

Report: Developing Opportunities within Mednax, Peabody Energy, NIC, Endologix, MobileIron, and QuinStreet — Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mednax, Inc (NYSE:MD), Peabody Energy Corporation (NYSE:BTU), NIC Inc....

Nov 07, 2018 07:02 pm ET

MEDNAX Announces Pricing of $500 Million of 6.250% Senior Notes Due 2027

MEDNAX, Inc. (NYSE: MD), announced today the pricing of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act. The expected closing date for the private placement of the Notes is Novembe

Nov 07, 2018 07:40 am ET

MEDNAX Launches Private Offering of $750 Million Senior Notes Due 2026

MEDNAX, Inc. (NYSE:MD), announced today that it is proposing to issue $750.0 million aggregate amount of senior notes due 2026 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The proposed offering is subject to market and other conditions.

Nov 06, 2018 06:45 am ET

MEDNAX to Present at Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

Nov 01, 2018 06:00 am ET

MEDNAX Reports Third Quarter GAAP EPS of $0.72; Adjusted EPS of $0.94

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.72 per diluted share for the three months ended September 30, 2018. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $0.94.

Nov 01, 2018 05:55 am ET

MEDNAX Announces Acquisition of Leading Tennessee Radiology Practice

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Associates in Diagnostic Radiology, P.C., a private radiology physician group based in Chattanooga, Tenn. The practice will integrate with Radiology Alliance, P.C., a MEDNAX-affiliated physician practice located in Nashville.

Oct 17, 2018 06:45 am ET

MEDNAX 2018 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 1, 2018

MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, November 1, 2018 at 10:00 a.m. ET, to discuss results from operations for the quarter and the nine months ended September 30, 2018. A detailed press release will be issued the morning of November 1, 2018 before the securities markets open.

Oct 12, 2018 08:10 am ET

Recent Analysis Shows Party City Holdco, Commercial Metals, MRC Global, DISH Network, Mednax, and Old Republic International Market Influences — Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Party City Holdco Inc. (NYSE:PRTY), Commercial Metals Company (NYSE:CMC),...

Oct 11, 2018 06:45 am ET

MEDNAX’s American Anesthesiology to Exhibit at the ANESTHESIOLOGY® 2018 Annual Meeting Oct. 13-15

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology, and management services, will exhibit at the ANESTHESIOLOGY® 2018 annual meeting presented by the American Society of Anesthesiologists (ASA) from Oct. 13-15 at the Mosc

Oct 10, 2018 06:45 am ET

MEDNAX Announces Acquisition of Large Neonatology Practice in South Florida

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of South Dade Neonatology, a private neonatology practice based in Miami.

Oct 09, 2018 07:45 am ET

Surgical Directions Names Dr. Katherine Grichnik Medical Director and Vice President of Clinical Development

Surgical Directions, a MEDNAX company (NYSE:MD) and leading healthcare consulting firm, is proud to announce Katherine Grichnik, M.D. as Medical Director and Vice President of Clinical Development. Dr. Grichnik, formerly a full professor at Duke University, will be responsible for helping clients transform their operating rooms to provide better patient outcomes, improve surgeon satisfaction and enhance profitability.

Oct 02, 2018 06:45 am ET

MEDNAX Announces Acquisition of Leading Nevada Radiology Practice

MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Radiology Specialists, LTD, a private radiology physician group based in Las Vegas. This marks the Company’s seventh radiology services practice acquisition and first in the state of Nevada, further establishing MEDNAX Radiology Solutions as a recognized leader in radiology, an innovator in health care informatics and a pioneer in telemedicine.

Sep 13, 2018 08:05 pm ET

MD LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mednax, Inc.; Important Deadline - MD

NEW YORK, Sept. 13, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Mednax, Inc. (NYSE: MD) from February 4, 2016 through July 27, 2017, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Mednax investors under the federal securities laws.

Sep 12, 2018 05:46 pm ET

Lifshitz & Miller LLP Announces Investigation of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetrapha

NEW YORK, Sept. 12, 2018 /PRNewswire/ --

Sep 12, 2018 06:45 am ET

MEDNAX Launches Audiology Institute: Nation’s Largest Provider of Newborn Hearing Screen Services Aims to Innovate the Care Delivery Model to Improve Patient Care and Access to Early Hearing Loss Iden

MEDNAX, Inc. (NYSE:MD), the nation’s largest provider of newborn hearing screen services, has launched the MEDNAX Audiology Institute, which will promote innovation and collaboration across all aspects of pediatric hearing loss – early detection, diagnosis and treatment – as well as quality and access to care. With more than 25 years

Sep 09, 2018 10:00 am ET

CLASS ACTION DEADLINE MONDAY for MRCY, MD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...

Sep 07, 2018 11:30 am ET

SHAREHOLDER ALERT: TSLA CBS LOGM GLCNF GLNCY NLSN MD FPI RMTI CRON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Sep 06, 2018 01:30 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PDD, NLSN, ZN, MD and GDS

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...

Sep 05, 2018 05:16 pm ET

CLASS ACTION UPDATE for ORCL, NLSN and MD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Sep 05, 2018 04:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rockwell Medical, MEDNAX, and Pinduoduo, and Encourages Investors to Contact the Firm

Bragar Eagel Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Rockwell Medical, Inc., MEDNAX, Inc., and Pinduoduo Inc. Stockholders have until the deadlines listed below to petition the...

Sep 05, 2018 03:59 pm ET

September 10th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against MEDNAX, Inc. (MD)

National securities litigation law firm Glancy Prongay & Murray LLP (“GPM”) reminds investors of the September 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased MEDNAX, Inc. (“Mednax” or the “Company) (NYSE:

Sep 05, 2018 12:37 pm ET

SHAREHOLDER ALERT: TSLA LOGM GLCNF ACAD MD FPI RMTI ABBV GDS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Sep 05, 2018 10:42 am ET

MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Mednax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Mednax, Inc. ("Mednax" or the "Company") (NYSE:

Sep 04, 2018 05:01 pm ET

Hagens Berman Reminds Investors in Mednax, Inc. (NYSE: MD) of the September 10, 2018 Securities Class Action Lead Plaintiff Deadline and Updates Investors Concerning CFO Departure

Hagens Berman Sobol Shapiro LLP reminds investors in Mednax, Inc. (NYSE: MD) of the September 10, 2018 Lead Plaintiff deadline in the pending securities class action. If you purchased or otherwise acquired Mednax securities between February 4,...

Sep 04, 2018 01:15 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD and TSLA

Sep 04, 2018 06:45 am ET

MEDNAX Commences $250 Million Accelerated Share Repurchase Program

MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the commencement of a $250 million accelerated share repurchase (ASR) program with Bank of America, N.A.

Sep 02, 2018 12:00 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, ACAD, RMTI and ABBV

Sep 01, 2018 01:36 pm ET

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mednax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mednax, Inc. ("Mednax" or the "Company") (NYSE:

Sep 01, 2018 11:00 am ET

MD LOSS NOTICE: Rosen Law Firm Reminds Mednax, Inc. Investors of Important September 10 Deadline in Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mednax, Inc. (NYSE: MD) from February 4, 2016 through July 27, 2017, inclusive (the “Class Period”) of the important September 10, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Mednax investors under the federal securities laws.

Aug 31, 2018 02:16 pm ET

CLASS ACTION UPDATE for MRCY and MD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 31, 2018 10:47 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD, FPI and ACAD

Aug 31, 2018 08:31 am ET

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Mednax, Inc. (NYS

Aug 30, 2018 06:40 pm ET

MD Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against MEDNAX, Inc. (MD)

Law Offices of Howard G. Smith reminds investors of the September 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased MEDNAX, Inc. (“Mednax” or the “Company”) (NYSE: MD) securities between February 4, 2016 to July 27, 2017, inclusive (the “Class Pe

Aug 30, 2018 12:54 pm ET

SHAREHOLDER ALERT: MRCY MD FPI ACAD TTPH FB ZN SBGI ORCL TSLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 29, 2018 07:55 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MEDNAX, Farmland Partners, and Vuzix and Encourages Investors to Contact the Firm

Bragar Eagel Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of MEDNAX, Inc., Farmland Partners Inc., and Vuzix Corporation. Stockholders have until the deadlines listed below to petition...

Aug 29, 2018 06:03 pm ET

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mednax, Inc. – MD

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Mednax, Inc. (NYSE:MD) from February 4, 2016 through July 27, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Mednax investors under the federal securities laws.

Aug 29, 2018 05:06 pm ET

CLASS ACTION UPDATE for MD and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 29, 2018 05:00 pm ET

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of MEDNAX, Inc. Investors

National securities litigation law firm Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased MEDNAX, Inc. (“Mednax” or the “Company”) (NYSE:

Aug 29, 2018 01:13 pm ET

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mednax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mednax, Inc. ("Mednax" or the "Company") (NYSE:

Aug 28, 2018 02:13 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD and FPI

Aug 26, 2018 10:00 am ET

SHAREHOLDER ALERT: MRCY GLNCY GLCNF MD COOL FPI FIZZ SBGL GOGO ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 24, 2018 05:36 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD

Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc. (“Mednax” or the “Company”) (NYSE: MD). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The...

Aug 24, 2018 11:00 am ET

CLASS ACTION UPDATE for MRCY, GLNCY and MD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 23, 2018 02:00 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, FPI, FIZZ, ACAD, TTPH and ABBV

Aug 23, 2018 06:45 am ET

MEDNAX Appoints Stephen D. Farber as Executive Vice President, to Succeed Chief Financial Officer

MEDNAX, Inc. (NYSE: MD) (the “Company”), today announced the appointment of Stephen D. Farber as Executive Vice President, effective August 27, 2018. The Company anticipates that Mr. Farber will assume the additional role of Chief Financial Officer in November 2018, following the Company’s release of its operating results for the period ending September 30, 2018, to succeed Vivian Lopez-Blanco, who recently announced her planned retirement from the Company.

Aug 22, 2018 11:38 am ET

CLASS ACTION UPDATE for MD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 21, 2018 06:31 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Funko, PolarityTE, and MEDNAX and Encourages Investors to Contact the Firm

Bragar Eagel Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Funko, Inc., PolarityTE, Inc., and MEDNAX, Inc. Stockholders have until the deadlines listed below to petition the court to...

Aug 21, 2018 06:22 pm ET

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of MEDNAX, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased MEDNAX, Inc. (“Mednax” or the “Company”) (NYSE: MD) securities between February 4, 2016 to July 27, 2017, inclusive (the “Class Period”). Mednax investors have until September 10, 2018 to

Aug 20, 2018 12:36 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, COOL, SBGL and GOGO

Aug 19, 2018 10:00 am ET

SHAREHOLDER ALERT: MRCY GLCNF GLNCY MD COOL HAIR FPI SBGL NWL GOGO FLKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 17, 2018 04:51 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD

Aug 16, 2018 01:00 pm ET

CLASS ACTION UPDATE for MD and NWL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 15, 2018 05:35 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, HAIR and ACAD

Aug 12, 2018 11:45 am ET

SHAREHOLDER ALERT: MRCY GLNCY GLCNF MD FPI FIZZ SBGL ACAD ABBV TTPH RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 11, 2018 08:11 am ET

DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Mednax, Inc. to Contact the Fi

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of Mednax, Inc. (NYSE: MD) (“Mednax” or the “Company”) securities during the period between February 4, 2016 to July 27, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until September 10, 2018 to seek appointment as lead plaintiff.

Aug 11, 2018 08:00 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mednax, Inc. - MD

Aug 10, 2018 08:30 am ET

New Research Coverage Highlights EOG Resources, Zimmer Biomet, MGIC Investment, EPR Properties, Guess?, and Mednax — Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EOG Resources, Inc. (NYSE:EOG), Zimmer Biomet Holdings, Inc. (NYSE:ZBH),...

Aug 09, 2018 01:26 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, FIZZ, TTPH, FB and HMNY

Aug 09, 2018 10:00 am ET

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against MEDNAX, Inc. (MD) and Lead Plaintiff Deadline – September 10, 2018

Attorney Advertising -- Bronstein, Gewirtz Grossman, LLC reminds investors that a class action lawsuit has been filed against MEDNAX, Inc. ("Mednax" or the "Company") (NYSE:MD) and certain of its officers, on behalf of shareholders who purchased...

Aug 06, 2018 12:16 pm ET

SHAREHOLDER ALERT: MD ORA SBGL NWL PCG ACAD RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 03, 2018 03:00 pm ET

CLASS ACTION UPDATE for MRCY, MD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Aug 02, 2018 10:22 am ET

SHAREHOLDER ALERT: MD ANW QCOM FIZZ NWL GOGO ACAD FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 02, 2018 06:00 am ET

MEDNAX Reports Second Quarter GAAP EPS of $0.85; Adjusted EPS of $1.07

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.85 per diluted share for the three months ended June 30, 2018. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $1.07.

Aug 01, 2018 06:22 pm ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, ORA and PCG

Aug 01, 2018 05:13 pm ET

Hagens Berman Reminds Investors in Mednax, Inc. (NYSE: MD) of the September 10, 2018 Securities Class Action Lead Plaintiff Deadline

Aug 01, 2018 11:00 am ET

SHAREHOLDER ALERT: MD ANW DB QCOM PCG ACAD RMTI FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Aug 01, 2018 08:01 am ET

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Mednax, Inc. (NYSE: MD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Clas

Jul 29, 2018 10:16 am ET

CLASS ACTION UPDATE for MRCY, MD and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Jul 25, 2018 06:45 am ET

MEDNAX to Exhibit at the 2018 American Hospital Association Leadership Summit July 26-27

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, will exhibit at the 2018 American Hospital Association (AHA) Leadership Summit from July 26-27 at the Manchester Grand Hyatt in San Diego, Calif

Jul 24, 2018 06:45 am ET

MEDNAX 2018 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 2, 2018

MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, August 2, 2018 at 10:00 a.m. ET, to discuss results from operations for the quarter and the six months ended June 30, 2018. A detailed press release will be issued the morning of August 2, 2018 before the securities markets open.

Jul 23, 2018 05:30 pm ET

SHAREHOLDER ALERT: MD ATEN ORA REVG NWL PCG GOGO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Jul 23, 2018 01:47 pm ET

Robbins Arroyo LLP: Mednax, Inc. Accused of Misstating Sustainability of its Business Model in Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Mednax, Inc. (NYSE: MD) filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between February 4, 2016 and July 27, 2017. Mednax, Inc. is a health

Jul 23, 2018 11:04 am ET

SHAREHOLDER ALERT: MD COOL HAIR TAL UNM QCOM FPI GOGO FLKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Jul 22, 2018 11:00 am ET

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, MD, GLCNF, FPI and SBGL

Jul 22, 2018 07:22 am ET

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Mednax, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action La

You are here

Pediatrix Medical Group Inc (N:MD)

Business Focus: Healthcare Facilities & Services